title: Use of non-insulin therapies for type 1 diabetes.
authors.affiliation: 1 Barbara Davis Center for Diabetes, University of Colorado Denver , Aurora, Colorado.
authors.forename: Satish K
authors.initials: SK
authors.lastname: Garg
authors.forename: Aaron W
authors.initials: AW
authors.lastname: Michels
authors.forename: Viral N
authors.initials: VN
authors.lastname: Shah
mesh_terms: D000499:Allylamine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000818:Animals; D001786:Blood Glucose / Q000187:drug effects; D001971:Bromocriptine / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000517:prevention & control; D000069472:Colesevelam Hydrochloride; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy* / Q000453:epidemiology; D003925:Diabetic Angiopathies / Q000517:prevention & control; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000627:therapeutic use*; D005755:Gastrins / Q000819:agonists; D052216:Glucagon-Like Peptide 1 / Q000031:analogs & derivatives / Q000627:therapeutic use; D006442:Glycated Hemoglobin / Q000187:drug effects; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced / Q000517:prevention & control; D007004:Hypoglycemic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D058228:Islet Amyloid Polypeptide / Q000819:agonists / Q000627:therapeutic use; D020738:Leptin / Q000031:analogs & derivatives / Q000627:therapeutic use; D008687:Metformin / Q000627:therapeutic use; D051269:Sodium-Glucose Transporter 1 / Q000037:antagonists & inhibitors; D051297:Sodium-Glucose Transporter 2; D000077203:Sodium-Glucose Transporter 2 Inhibitors; D013453:Sulfonylurea Compounds / Q000627:therapeutic use; D045162:Thiazolidinediones / Q000627:therapeutic use; D014481:United States / Q000453:epidemiology
chemical_list: D000499:Allylamine; D001786:Blood Glucose; D001971:Bromocriptine; D000069472:Colesevelam Hydrochloride; D054873:Dipeptidyl-Peptidase IV Inhibitors; D005755:Gastrins; D052216:Glucagon-Like Peptide 1; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D058228:Islet Amyloid Polypeptide; D020738:Leptin; D008687:Metformin; D051269:Sodium-Glucose Transporter 1; D051297:Sodium-Glucose Transporter 2; D000077203:Sodium-Glucose Transporter 2 Inhibitors; D013453:Sulfonylurea Compounds; D045162:Thiazolidinediones; C495674:SLC5A1 protein, human; C089180:SLC5A2 protein, human; C517652:hemoglobin A1c protein, human; C415771:metreleptin